Vaccines for treatment of lymphoma and leukemia
US7419660B1 · kind B1 · utility
4Cited by
10References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 9, 1999 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Aug 9, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias). The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune cell tumors malignancies as well as methods of treating immune cell tumors using custom vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.